Status:
TERMINATED
New Horizons for the Treatment of Cardiomyopathy in Children
Lead Sponsor:
Damascus University
Conditions:
Cardiomyopathy
Eligibility:
All Genders
6-14 years
Phase:
NA
Brief Summary
Collecting mono nuclear cells from the patient's blood after a course of granulocyte stimulation then injecting them into the weak heart muscle measuring the heart function at the beginning and after ...
Detailed Description
Dilated cardiomyopathy in children has high morbidity and mortality, current treatment doesn't improve the prognosis and the only cure available is heart transplantation which is limited, has long wai...
Eligibility Criteria
Inclusion
- Dilated cardiomyopathy diagnosed and treated at least 6 mo. Ago
- LVEF less than 40%
- Use of I.V inotropes
Exclusion
- Acute infection
- Severe organ failure (other than the heart)
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04893629
Start Date
May 20 2021
End Date
November 30 2024
Last Update
February 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children'S Hospital
Damascus, Syria, 011